12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile

C135H125N33O5 — CID 159180429

IUPAC12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile
SMILESCN1CCC(Oc2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1.COC1(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CCNCC1.COc1cc(-c2cnc3[nH]c4cnc(C#N)cc4c3c2)cc(OC)c1CN1CCCCC1.N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(C4(O)CCNCC4)cc3)cc12.N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCNCC4)cc3)cc12.N#Cc1cc2c(cn1)[nH]c1ncc(-c3cnn(CCN4CCCC4)c3)cc12
InChIInChI=1S/C25H25N5O2.2C23H21N5O.C22H20N6.C22H19N5O.C20H19N7/c1-31-23-9-16(10-24(32-2)21(23)15-30-6-4-3-5-7-30)17-8-20-19-11-18(12-26)27-14-22(19)29-25(20)28-13-17;1-28-8-6-19(7-9-28)29-18-4-2-15(3-5-18)16-10-21-20-11-17(12-24)25-14-22(20)27-23(21)26-13-16;1-29-23(6-8-25-9-7-23)17-4-2-15(3-5-17)16-10-20-19-11-18(12-24)26-14-21(19)28-22(20)27-13-16;23-11-18-10-19-20-9-17(12-26-22(20)27-21(19)13-25-18)16-3-1-15(2-4-16)14-28-7-5-24-6-8-28;23-11-17-10-18-19-9-15(12-26-21(19)27-20(18)13-25-17)14-1-3-16(4-2-14)22(28)5-7-24-8-6-22;21-9-16-8-17-18-7-14(10-23-20(18)25-19(17)12-22-16)15-11-24-27(13-15)6-5-26-3-1-2-4-26/h8-11,13-14H,3-7,15H2,1-2H3,(H,28,29);2-5,10-11,13-14,19H,6-9H2,1H3,(H,26,27);2-5,10-11,13-14,25H,6-9H2,1H3,(H,27,28);1-4,9-10,12-13,24H,5-8,14H2,(H,26,27);1-4,9-10,12-13,24,28H,5-8H2,(H,26,27);7-8,10-13H,1-6H2,(H,23,25)
InChIKeyKMUWUECFLIRUGF-UHFFFAOYSA-N
MW2289.71 g/mol
LogP21.87
Rot. Bonds20

About 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile

12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile (PubChem CID 159180429) has the molecular formula C135H125N33O5 and a molecular weight of 2289.71 g/mol. Its IUPAC name is 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile.

Molecular Properties

Compound Name12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile
PubChem CID159180429
Molecular FormulaC135H125N33O5
Molecular Weight2289.71 g/mol
Exact Mass2288.05
IUPAC Name12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile
SMILESCN1CCC(Oc2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1.COC1(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CCNCC1.COc1cc(-c2cnc3[nH]c4cnc(C#N)cc4c3c2)cc(OC)c1CN1CCCCC1.N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(C4(O)CCNCC4)cc3)cc12.N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCNCC4)cc3)cc12.N#Cc1cc2c(cn1)[nH]c1ncc(-c3cnn(CCN4CCCC4)c3)cc12
InChIInChI=1S/C25H25N5O2.2C23H21N5O.C22H20N6.C22H19N5O.C20H19N7/c1-31-23-9-16(10-24(32-2)21(23)15-30-6-4-3-5-7-30)17-8-20-19-11-18(12-26)27-14-22(19)29-25(20)28-13-17;1-28-8-6-19(7-9-28)29-18-4-2-15(3-5-18)16-10-21-20-11-17(12-24)25-14-22(20)27-23(21)26-13-16;1-29-23(6-8-25-9-7-23)17-4-2-15(3-5-17)16-10-20-19-11-18(12-24)26-14-21(19)28-22(20)27-13-16;23-11-18-10-19-20-9-17(12-26-22(20)27-21(19)13-25-18)16-3-1-15(2-4-16)14-28-7-5-24-6-8-28;23-11-17-10-18-19-9-15(12-26-21(19)27-20(18)13-25-17)14-1-3-16(4-2-14)22(28)5-7-24-8-6-22;21-9-16-8-17-18-7-14(10-23-20(18)25-19(17)12-22-16)15-11-24-27(13-15)6-5-26-3-1-2-4-26/h8-11,13-14H,3-7,15H2,1-2H3,(H,28,29);2-5,10-11,13-14,19H,6-9H2,1H3,(H,26,27);2-5,10-11,13-14,25H,6-9H2,1H3,(H,27,28);1-4,9-10,12-13,24H,5-8,14H2,(H,26,27);1-4,9-10,12-13,24,28H,5-8H2,(H,26,27);7-8,10-13H,1-6H2,(H,23,25)
InChIKeyKMUWUECFLIRUGF-UHFFFAOYSA-N
XLogP21.87
TPSA516.18 Ų
H-Bond Donors10
H-Bond Acceptors32
Rotatable Bonds20
Heavy Atoms173
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002289.71
LogP ≤ 521.87
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1032

Analyze 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile?
The IUPAC name of 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile (CID 159180429) is 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile.
What is the SMILES notation for 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile?
The canonical SMILES for 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile is CN1CCC(Oc2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1.COC1(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CCNCC1.COc1cc(-c2cnc3[nH]c4cnc(C#N)cc4c3c2)cc(OC)c1CN1CCCCC1.N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(C4(O)CCNCC4)cc3)cc12.N#Cc1cc2c(cn1)[nH]c1ncc(-c3ccc(CN4CCNCC4)cc3)cc12.N#Cc1cc2c(cn1)[nH]c1ncc(-c3cnn(CCN4CCCC4)c3)cc12.
What is the InChIKey of 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile?
The InChIKey is KMUWUECFLIRUGF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H25N5O2.2C23H21N5O.C22H20N6.C22H19N5O.C20H19N7/c1-31-23-9-16(10-24(32-2)21(23)15-30-6-4-3-5-7-30)17-8-20-19-11-18(12-26)27-14-22(19)29-25(20)28-13-17;1-28-8-6-19(7-9-28)29-18-4-2-15(3-5-18)16-10-21-20-11-17(12-24)25-14-22(20)27-23(21)26-13-16;1-29-23(6-8-25-9-7-23)17-4-2-15(3-5-17)16-10-20-19-11-18(12-24)26-14-21(19)28-22(20)27-13-16;23-11-18-10-19-20-9-17(12-26-22(20)27-21(19)13-25-18)16-3-1-15(2-4-16)14-28-7-5-24-6-8-28;23-11-17-10-18-19-9-15(12-26-21(19)27-20(18)13-25-17)14-1-3-16(4-2-14)22(28)5-7-24-8-6-22;21-9-16-8-17-18-7-14(10-23-20(18)25-19(17)12-22-16)15-11-24-27(13-15)6-5-26-3-1-2-4-26/h8-11,13-14H,3-7,15H2,1-2H3,(H,28,29);2-5,10-11,13-14,19H,6-9H2,1H3,(H,26,27);2-5,10-11,13-14,25H,6-9H2,1H3,(H,27,28);1-4,9-10,12-13,24H,5-8,14H2,(H,26,27);1-4,9-10,12-13,24,28H,5-8H2,(H,26,27);7-8,10-13H,1-6H2,(H,23,25).
What are the key properties of 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile?
12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile has a molecular weight of 2289.71 g/mol, XLogP of 21.87, 20 rotatable bonds, 10 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 12-[3,5-dimethoxy-4-(piperidin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-hydroxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(4-methoxypiperidin-4-yl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(1-methylpiperidin-4-yl)oxyphenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[4-(piperazin-1-ylmethyl)phenyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile;12-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene-4-carbonitrile is sourced from PubChem (CID 159180429), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).